Together M-Theory and StringTheory create a comprehensive set of data that can be leveraged for commercial and academic purposes, allowing research into the effects and benefits of various strains, chemovars or other manufacturing formulations. FumiWare is committed to making data open to non-profit and academic organizations and protecting the anonymity of our end users.
StringTheory strives to fill two significant voids in the
cannabis industry by creating an integrative solution for complying with local regulatory and
business requirements affecting the cannabis industry and by providing aggregated data and
information about various strains to consumers and educators to facilitate research.
The need for quality data on cannabis is great, but not just for the profit-focused few who use cannabis to create individual wealth. Doctors are increasingly looking at cannabis to ease suffering and increase quality of life for everyone from cancer patients to people with debilitating anxiety disorders. The more we learn about cannabis, the greater good we can do for the world.
Because cannabis had been illegal for so many years, the federal framework has left researchers and educators with limited quality information about cannabis with which to conduct their research. StringTheory wants to make right and do good. By collecting information throughout the cannabis lifecycle, including its medical uses, StringTheory can help companies comply with state and international law, and also supply much-needed data to the research community to further medical goals.
FumiWare has a global tech team with members in San Francisco, Chicago and Odessa. Ready to scale fast.
FumiWare's founders have expertise in all aspects of software and database management including product and application performance, scalability, database systems and security. Collectively, their experience in the software development and management industry translates to a superior product that addresses the biggest challenges facing cannabis industry businesses today.
Advisors include: Deborah Small, Shabnam Malek, Rae Wedel, Phil Guziec
We're testing and advancing as you read this.
Email us for more information.
Want to the a beta tester? Help us improve our product!